| ||
Name: tert-butyl {(3r,5r)-1-[2-amino-6-(3-amino-2h-indazol-6-yl)pyrimidin-4-yl]-5-methylpiperidin-3-yl}carbamate | ||
Formula: C22 H30 N8 O2 | ||
Weight: 438.526 | ||
SMILES: "C[CH]1C[CH](CN(C1)c2cc(nc(N)n2)c3ccc4c(N)[nH]nc4c3)NC(=O)OC(C)(C)C" | ||
Spacial conformation based on PDB 3qd4 |
RESIDUE 3Q6 62 CONECT C1 3 C2 C5 H1 CONECT C2 3 C1 C6 H2 CONECT C3 3 C6 C7 H3 CONECT C4 3 C8 C9 H4 CONECT C5 3 C1 C7 C10 CONECT C6 3 C2 C3 C8 CONECT C7 3 C3 C5 N26 CONECT C8 3 C4 C6 N23 CONECT C9 3 C4 N24 N27 CONECT C10 3 C5 N25 N28 CONECT C11 3 N23 N24 N29 CONECT C12 3 N30 O31 O32 CONECT C13 4 C16 C17 H13 H13A CONECT C14 4 C16 N27 H14 H14A CONECT C15 4 C17 N27 H15 H15A CONECT C16 4 C13 C14 C18 H16 CONECT C17 4 C13 C15 N30 H17 CONECT C18 4 C16 H18 H18A H18B CONECT C19 4 C22 H19 H19A H19B CONECT C20 4 C22 H20 H20A H20B CONECT C21 4 C22 H21 H21A H21B CONECT C22 4 C19 C20 C21 O32 CONECT N23 2 C8 C11 CONECT N24 2 C9 C11 CONECT N25 3 C10 N26 HN25 CONECT N26 2 C7 N25 CONECT N27 3 C9 C14 C15 CONECT N28 3 C10 HN28 HN2A CONECT N29 3 C11 HN29 HN2B CONECT N30 3 C12 C17 HN30 CONECT O31 1 C12 CONECT O32 2 C12 C22 CONECT H1 1 C1 CONECT H2 1 C2 CONECT H3 1 C3 CONECT H4 1 C4 CONECT H13 1 C13 CONECT H13A 1 C13 CONECT H14 1 C14 CONECT H14A 1 C14 CONECT H15 1 C15 CONECT H15A 1 C15 CONECT H16 1 C16 CONECT H17 1 C17 CONECT H18 1 C18 CONECT H18A 1 C18 CONECT H18B 1 C18 CONECT H19 1 C19 CONECT H19A 1 C19 CONECT H19B 1 C19 CONECT H20 1 C20 CONECT H20A 1 C20 CONECT H20B 1 C20 CONECT H21 1 C21 CONECT H21A 1 C21 CONECT H21B 1 C21 CONECT HN28 1 N28 CONECT HN2A 1 N28 CONECT HN29 1 N29 CONECT HN2B 1 N29 CONECT HN30 1 N30 CONECT HN25 1 N25 END HET 3Q6 62 HETNAM 3Q6 tert-butyl {(3R,5R)-1-[2-amino-6-(3-amino-2H-indazol-6- HETNAM 2 3Q6 yl)pyrimidin-4-yl]-5-methylpiperidin-3-yl}carbamate FORMUL 3Q6 C22 H30 N8 O2
This OCA
MONOMER page uses Jmol, developed by the Jmol Development Team (color reference)
|